|
|
keratinization
|
GO:0031424 |
9 |
0.691
|
|
|
|
intermediate filament cytoskeleton organization
|
GO:0045104 |
26 |
0.662
|
|
|
|
intermediate filament based process
|
GO:0045103 |
27 |
0.657
|
|
|
|
regulation of keratinocyte differentiation
|
GO:0045616 |
11 |
0.651
|
|
|
|
multicellular organismal water homeostasis
|
GO:0050891 |
23 |
0.629
|
|
|
|
keratinocyte differentiation
|
GO:0030216 |
48 |
0.589
|
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.586
|
|
|
|
hepatocyte apoptotic process
|
GO:0097284 |
11 |
0.511
|
|
|
|
regulation of epidermal cell differentiation
|
GO:0045604 |
21 |
0.486
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.462
|
|
|
|
hair follicle morphogenesis
|
GO:0031069 |
29 |
0.419
|
|
|
|
cytokine mediated signaling pathway
|
GO:0019221 |
115 |
0.316
|
|
|
|
intermediate filament organization
|
GO:0045109 |
15 |
0.287
|
|
|
|
negative regulation of epithelial cell proliferation
|
GO:0050680 |
64 |
0.281
|
|
|
|
hair cycle
|
GO:0042633 |
90 |
0.280
|
|
|
|
molting cycle
|
GO:0042303 |
90 |
0.264
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.254
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.252
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.252
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.250
|
|
|
|
sensory perception of light stimulus
|
GO:0050953 |
54 |
0.247
|
|
|
|
cell differentiation involved in embryonic placenta development
|
GO:0060706 |
26 |
0.233
|
|
|
|
epidermis morphogenesis
|
GO:0048730 |
33 |
0.231
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.228
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.216
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.216
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.215
|
|
|
|
positive regulation of dopamine secretion
|
GO:0033603 |
2 |
0.190
|
|
|
|
regulation of epidermis development
|
GO:0045682 |
33 |
0.186
|
|
|
|
protein processing
|
GO:0016485 |
163 |
0.184
|
|
|
|
dendrite development
|
GO:0016358 |
115 |
0.180
|
|
|
|
striated muscle contraction
|
GO:0006941 |
45 |
0.176
|
|
|
|
skin morphogenesis
|
GO:0043589 |
38 |
0.169
|
|
|
|
water homeostasis
|
GO:0030104 |
27 |
0.168
|
|
|
|
tissue regeneration
|
GO:0042246 |
22 |
0.167
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.166
|
|
|
|
catecholamine secretion
|
GO:0050432 |
15 |
0.164
|
|
|
|
positive regulation of hair follicle development
|
GO:0051798 |
6 |
0.161
|
|
|
|
regulation of water loss via skin
|
GO:0033561 |
16 |
0.158
|
|
|
|
negative regulation of action potential
|
GO:0045759 |
1 |
0.157
|
|
|
|
tumor necrosis factor mediated signaling pathway
|
GO:0033209 |
13 |
0.151
|
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.149
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.149
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.145
|
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.144
|
|
|
|
negative regulation of inflammatory response
|
GO:0050728 |
61 |
0.141
|
|
|
|
extrinsic apoptotic signaling pathway
|
GO:0097191 |
126 |
0.138
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.137
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.133
|
|
|
|
epinephrine secretion
|
GO:0048242 |
1 |
0.131
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.128
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.126
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.120
|
|
|
|
regeneration
|
GO:0031099 |
38 |
0.118
|
|
|
|
hair follicle development
|
GO:0001942 |
85 |
0.118
|
|
|
|
synaptic transmission involved in micturition
|
GO:0060084 |
3 |
0.117
|
|
|
|
acetylcholine secretion neurotransmission
|
GO:0014055 |
2 |
0.114
|
|
|
|
establishment of skin barrier
|
GO:0061436 |
14 |
0.112
|
|
|
|
positive regulation of heart rate involved in baroreceptor response to decreased systemic arterial blood pressure
|
GO:0001988 |
1 |
0.108
|
|
|
|
norepinephrine transport
|
GO:0015874 |
2 |
0.108
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.107
|
|
|
|
arachidonic acid metabolite production involved in inflammatory response
|
GO:0002538 |
2 |
0.103
|
|
|
|
epinephrine transport
|
GO:0048241 |
1 |
0.100
|
|
|
|
positive regulation of epidermis development
|
GO:0045684 |
13 |
0.096
|
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.091
|
|
|
|
regulation of norepinephrine secretion
|
GO:0014061 |
2 |
0.090
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.090
|
|
|
|
norepinephrine secretion
|
GO:0048243 |
2 |
0.087
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.086
|
|
|
|
regulation of inflammatory response
|
GO:0050727 |
147 |
0.086
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.085
|
|
|
|
cellular ion homeostasis
|
GO:0006873 |
165 |
0.084
|
|
|
|
regulation of peptidase activity
|
GO:0052547 |
96 |
0.083
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.083
|
|
|
|
generation of ovulation cycle rhythm
|
GO:0060112 |
1 |
0.082
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.081
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.080
|
|
|
|
regulation of actin filament based process
|
GO:0032970 |
99 |
0.080
|
|
|
|
regulation of circadian sleep wake cycle rem sleep
|
GO:0042320 |
1 |
0.080
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.079
|
|
|
|
cellular response to metal ion
|
GO:0071248 |
31 |
0.077
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.074
|
|
|
|
action potential
|
GO:0001508 |
78 |
0.073
|
|
|
|
cardiac muscle tissue development
|
GO:0048738 |
130 |
0.072
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.071
|
|
|
|
placenta development
|
GO:0001890 |
140 |
0.071
|
|
|
|
negative regulation of defense response
|
GO:0031348 |
77 |
0.070
|
|
|
|
regulation of action potential
|
GO:0098900 |
4 |
0.070
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.069
|
|
|
|
cellular response to calcium ion
|
GO:0071277 |
14 |
0.068
|
|
|
|
renal vesicle induction
|
GO:0072034 |
3 |
0.067
|
|
|
|
response to tumor necrosis factor
|
GO:0034612 |
26 |
0.066
|
|
|
|
muscle system process
|
GO:0003012 |
141 |
0.065
|
|
|
|
regulation of feeding behavior
|
GO:0060259 |
3 |
0.065
|
|
|
|
kidney development
|
GO:0001822 |
213 |
0.064
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.063
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.062
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.062
|
|
|
|
renal system process
|
GO:0003014 |
48 |
0.061
|
|
|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.060
|
|
|
|
regulation of protein processing
|
GO:0070613 |
96 |
0.059
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.059
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.059
|
|
|
|
heart contraction
|
GO:0060047 |
93 |
0.058
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.057
|
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
189 |
0.057
|
|
|
|
lipoxygenase pathway
|
GO:0019372 |
5 |
0.056
|
|
|
|
organelle localization
|
GO:0051640 |
179 |
0.055
|
|
|
|
response to metal ion
|
GO:0010038 |
47 |
0.053
|
|
|
|
regulation of acetylcholine secretion neurotransmission
|
GO:0014056 |
2 |
0.052
|
|
|
|
cellular potassium ion transport
|
GO:0071804 |
43 |
0.052
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.052
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.052
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.050
|
|
|
|
retina development in camera type eye
|
GO:0060041 |
119 |
0.050
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.050
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.049
|
|
|
|
cofactor transport
|
GO:0051181 |
4 |
0.049
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.049
|
|
|
|
retinal cone cell development
|
GO:0046549 |
8 |
0.048
|
|
|
|
circadian sleep wake cycle rem sleep
|
GO:0042747 |
1 |
0.048
|
|
|
|
cellular response to amino acid stimulus
|
GO:0071230 |
29 |
0.046
|
|
|
|
naphthalene containing compound metabolic process
|
GO:0090420 |
1 |
0.046
|
|
|
|
calcium ion homeostasis
|
GO:0055074 |
127 |
0.046
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.046
|
|
|
|
organic acid biosynthetic process
|
GO:0016053 |
86 |
0.045
|
|
|
|
response to denervation involved in regulation of muscle adaptation
|
GO:0014894 |
4 |
0.045
|
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.044
|
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
151 |
0.042
|
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.042
|
|
|
|
plasma membrane organization
|
GO:0007009 |
90 |
0.042
|
|
|
|
positive regulation of catecholamine secretion
|
GO:0033605 |
2 |
0.042
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.041
|
|
|
|
positive regulation of cell growth
|
GO:0030307 |
33 |
0.041
|
|
|
|
planar cell polarity pathway involved in ventricular septum morphogenesis
|
GO:0061348 |
2 |
0.040
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.039
|
|
|
|
embryonic placenta development
|
GO:0001892 |
98 |
0.039
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.039
|
|
|
|
cellular response to tumor necrosis factor
|
GO:0071356 |
21 |
0.038
|
|
|
|
regulation of cell growth
|
GO:0001558 |
91 |
0.038
|
|
|
|
negative regulation of protein serine threonine kinase activity
|
GO:0071901 |
49 |
0.038
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.037
|
|
|
|
sodium ion transmembrane transport
|
GO:0035725 |
49 |
0.037
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.037
|
|
|
|
heart process
|
GO:0003015 |
94 |
0.037
|
|
|
|
hormone secretion
|
GO:0046879 |
128 |
0.037
|
|
|
|
regulation of satellite cell activation involved in skeletal muscle regeneration
|
GO:0014717 |
3 |
0.036
|
|
|
|
regulation of interleukin 1 beta production
|
GO:0032651 |
25 |
0.036
|
|
|
|
muscle contraction
|
GO:0006936 |
101 |
0.036
|
|
|
|
extracellular matrix organization
|
GO:0030198 |
147 |
0.036
|
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
157 |
0.036
|
|
|
|
response to radiation
|
GO:0009314 |
165 |
0.035
|
|
|
|
negative regulation of response to wounding
|
GO:1903035 |
77 |
0.035
|
|
|
|
response to light stimulus
|
GO:0009416 |
135 |
0.035
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.035
|
|
|
|
cell communication by electrical coupling involved in cardiac conduction
|
GO:0086064 |
2 |
0.035
|
|
|
|
keratinocyte proliferation
|
GO:0043616 |
21 |
0.034
|
|
|
|
regulation of engulfment of apoptotic cell
|
GO:1901074 |
2 |
0.034
|
|
|
|
mitral valve development
|
GO:0003174 |
4 |
0.034
|
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.033
|
|
|
|
divalent inorganic cation homeostasis
|
GO:0072507 |
138 |
0.033
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.033
|
|
|
|
cellular response to acid chemical
|
GO:0071229 |
68 |
0.033
|
|
|
|
response to iron ion
|
GO:0010039 |
4 |
0.033
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.033
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.033
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.033
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.033
|
|
|
|
cellular response to inorganic substance
|
GO:0071241 |
37 |
0.032
|
|
|
|
response to amino acid
|
GO:0043200 |
37 |
0.032
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.032
|
|
|
|
cation transmembrane transport
|
GO:0098655 |
266 |
0.032
|
|
|
|
lateral geniculate nucleus development
|
GO:0021771 |
1 |
0.032
|
|
|
|
organ growth
|
GO:0035265 |
117 |
0.032
|
|
|
|
carboxylic acid biosynthetic process
|
GO:0046394 |
86 |
0.032
|
|
|
|
positive regulation of hair cycle
|
GO:0042635 |
7 |
0.032
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
188 |
0.032
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.031
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.031
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.031
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.031
|
|
|
|
cellularization
|
GO:0007349 |
1 |
0.031
|
|
|
|
regulation of catecholamine secretion
|
GO:0050433 |
12 |
0.030
|
|
|
|
purinergic nucleotide receptor signaling pathway
|
GO:0035590 |
3 |
0.030
|
|
|
|
fatty acid metabolic process
|
GO:0006631 |
121 |
0.030
|
|
|
|
extracellular structure organization
|
GO:0043062 |
148 |
0.030
|
|
|
|
regulation of heart rate
|
GO:0002027 |
36 |
0.030
|
|
|
|
microtubule cytoskeleton organization
|
GO:0000226 |
157 |
0.030
|
|
|
|
organelle assembly
|
GO:0070925 |
177 |
0.030
|
|
|
|
regulation of heart contraction
|
GO:0008016 |
77 |
0.029
|
|
|
|
cell growth
|
GO:0016049 |
130 |
0.029
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.029
|
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.029
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.029
|
|
|
|
peptidyl serine modification
|
GO:0018209 |
83 |
0.029
|
|
|
|
negative regulation of map kinase activity
|
GO:0043407 |
34 |
0.029
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.028
|
|
|
|
regulation of interleukin 6 production
|
GO:0032675 |
55 |
0.028
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.028
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.028
|
|
|
|
monoamine transport
|
GO:0015844 |
33 |
0.028
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.028
|
|
|
|
regulation of muscle tissue development
|
GO:1901861 |
97 |
0.028
|
|
|
|
chromatin organization
|
GO:0006325 |
206 |
0.027
|
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.027
|
|
|
|
activation of transmembrane receptor protein tyrosine kinase activity
|
GO:0007171 |
3 |
0.027
|
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.027
|
|
|
|
negative regulation of hydrolase activity
|
GO:0051346 |
71 |
0.027
|
|
|
|
cellular response to salt stress
|
GO:0071472 |
1 |
0.027
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.027
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.027
|
|
|
|
regulation of endopeptidase activity
|
GO:0052548 |
89 |
0.026
|
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.026
|
|
|
|
cellular modified amino acid metabolic process
|
GO:0006575 |
63 |
0.026
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.026
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.026
|
|
|
|
neuron migration
|
GO:0001764 |
122 |
0.026
|
|
|
|
acetylcholine transport
|
GO:0015870 |
2 |
0.026
|
|
|
|
regulation of hair cycle
|
GO:0042634 |
11 |
0.025
|
|
|
|
sensory perception of mechanical stimulus
|
GO:0050954 |
107 |
0.025
|
|
|
|
odontogenesis of dentin containing tooth
|
GO:0042475 |
66 |
0.025
|
|
|
|
central nervous system vasculogenesis
|
GO:0022009 |
3 |
0.025
|
|
|
|
positive regulation of ion transport
|
GO:0043270 |
65 |
0.025
|
|
|
|
leukocyte proliferation
|
GO:0070661 |
172 |
0.025
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.025
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.025
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.024
|
|
|
|
myoblast differentiation
|
GO:0045445 |
52 |
0.024
|
|
|
|
organic hydroxy compound transport
|
GO:0015850 |
93 |
0.024
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.024
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.024
|
|
|
|
interleukin 6 production
|
GO:0032635 |
58 |
0.024
|
|
|
|
regulation of blood vessel size by renin angiotensin
|
GO:0002034 |
5 |
0.024
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.024
|
|
|
|
regulation of renin secretion into blood stream
|
GO:1900133 |
4 |
0.024
|
|
|
|
engulfment of apoptotic cell
|
GO:0043652 |
3 |
0.024
|
|
|
|
nephron epithelium development
|
GO:0072009 |
92 |
0.024
|
|
|
|
regulation of systemic arterial blood pressure
|
GO:0003073 |
61 |
0.023
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.023
|
|
|
|
negative regulation of keratinocyte proliferation
|
GO:0010839 |
7 |
0.023
|
|
|
|
salivary gland morphogenesis
|
GO:0007435 |
33 |
0.023
|
|
|
|
canonical wnt signaling pathway involved in regulation of type b pancreatic cell proliferation
|
GO:0044343 |
1 |
0.023
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.023
|
|
|
|
negative regulation of synapse assembly
|
GO:0051964 |
3 |
0.023
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.023
|
|
|
|
satellite cell activation involved in skeletal muscle regeneration
|
GO:0014901 |
3 |
0.023
|
|
|
|
cardiac muscle contraction
|
GO:0060048 |
32 |
0.023
|
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.023
|
|
|
|
regulation of translation
|
GO:0006417 |
71 |
0.023
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.023
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.023
|
|
|
|
small molecule biosynthetic process
|
GO:0044283 |
132 |
0.023
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.022
|
|
|
|
translation
|
GO:0006412 |
93 |
0.022
|
|
|
|
cardiac chamber development
|
GO:0003205 |
108 |
0.022
|
|
|
|
regulation of hair follicle development
|
GO:0051797 |
9 |
0.022
|
|
|
|
regulation of ion transport
|
GO:0043269 |
215 |
0.022
|
|
|
|
regulation of transmembrane transport
|
GO:0034762 |
128 |
0.022
|
|
|
|
inorganic ion transmembrane transport
|
GO:0098660 |
234 |
0.022
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
199 |
0.022
|
|
|
|
sulfur compound metabolic process
|
GO:0006790 |
100 |
0.022
|
|
|
|
fibrinolysis
|
GO:0042730 |
3 |
0.022
|
|
|
|
regulation of systemic arterial blood pressure mediated by a chemical signal
|
GO:0003044 |
33 |
0.022
|
|
|
|
regulation of lipid transport
|
GO:0032368 |
36 |
0.022
|
|
|
|
striated muscle cell development
|
GO:0055002 |
125 |
0.022
|
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.022
|
|
|
|
detection of abiotic stimulus
|
GO:0009582 |
60 |
0.022
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.021
|
|
|
|
lymphocyte proliferation
|
GO:0046651 |
164 |
0.021
|
|
|
|
tube lumen cavitation
|
GO:0060605 |
5 |
0.021
|
|
|
|
regulation of blood circulation
|
GO:1903522 |
93 |
0.021
|
|
|
|
regulation of circadian sleep wake cycle non rem sleep
|
GO:0045188 |
1 |
0.021
|
|
|
|
negative regulation of transferase activity
|
GO:0051348 |
85 |
0.021
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.021
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.021
|
|
|
|
defecation
|
GO:0030421 |
1 |
0.021
|
|
|
|
regulation of map kinase activity
|
GO:0043405 |
120 |
0.021
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.021
|
|
|
|
regulation of immunological synapse formation
|
GO:2000520 |
2 |
0.020
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.020
|
|
|
|
cardiac muscle tissue morphogenesis
|
GO:0055008 |
44 |
0.020
|
|
|
|
ventricular cardiac muscle tissue morphogenesis
|
GO:0055010 |
32 |
0.020
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.020
|
|
|
|
regulation of skeletal muscle fiber development
|
GO:0048742 |
36 |
0.020
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.020
|
|
|
|
lipid localization
|
GO:0010876 |
126 |
0.020
|
|
|
|
negative regulation of interleukin 1 beta production
|
GO:0032691 |
5 |
0.020
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.020
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.020
|
|
|
|
otic placode formation
|
GO:0043049 |
1 |
0.020
|
|
|
|
detection of external stimulus
|
GO:0009581 |
61 |
0.020
|
|
|
|
embryonic epithelial tube formation
|
GO:0001838 |
130 |
0.020
|
|
|
|
visual perception
|
GO:0007601 |
52 |
0.020
|
|
|
|
columnar cuboidal epithelial cell differentiation
|
GO:0002065 |
82 |
0.019
|
|
|
|
developmental growth involved in morphogenesis
|
GO:0060560 |
138 |
0.019
|
|
|
|
neuron death
|
GO:0070997 |
154 |
0.019
|
|
|
|
potassium ion transport
|
GO:0006813 |
52 |
0.019
|
|
|
|
regulation of protein transport
|
GO:0051223 |
163 |
0.019
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.019
|
|
|
|
regulation of tube size
|
GO:0035150 |
57 |
0.019
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.019
|
|
|
|
lipid catabolic process
|
GO:0016042 |
69 |
0.019
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.019
|
|
|
|
interleukin 1 production
|
GO:0032612 |
31 |
0.019
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.018
|
|
|
|
myeloid cell homeostasis
|
GO:0002262 |
114 |
0.018
|
|
|
|
oxygen homeostasis
|
GO:0032364 |
2 |
0.018
|
|
|
|
negative regulation of protein maturation
|
GO:1903318 |
79 |
0.018
|
|
|
|
multicellular organismal signaling
|
GO:0035637 |
91 |
0.018
|
|
|
|
circadian sleep wake cycle non rem sleep
|
GO:0042748 |
2 |
0.018
|
|
|
|
dopamine secretion
|
GO:0014046 |
9 |
0.018
|
|
|
|
regulation of transcription from rna polymerase ii promoter involved in forebrain neuron fate commitment
|
GO:0021882 |
3 |
0.018
|
|
|
|
negative regulation of cell activation
|
GO:0050866 |
111 |
0.018
|
|
|
|
positive regulation of interleukin 8 production
|
GO:0032757 |
2 |
0.018
|
|
|
|
regulation of ras protein signal transduction
|
GO:0046578 |
114 |
0.018
|
|
|
|
sa node cell to atrial cardiac muscle cell signalling
|
GO:0086018 |
4 |
0.018
|
|
|
|
negative regulation of peptidase activity
|
GO:0010466 |
46 |
0.017
|
|
|
|
divalent metal ion transport
|
GO:0070838 |
172 |
0.017
|
|
|
|
renal tubular secretion
|
GO:0097254 |
2 |
0.017
|
|
|
|
protein secretion
|
GO:0009306 |
111 |
0.017
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
160 |
0.017
|
|
|
|
limb development
|
GO:0060173 |
166 |
0.017
|
|
|
|
compound eye development
|
GO:0048749 |
1 |
0.017
|
|
|
|
leukocyte apoptotic process
|
GO:0071887 |
71 |
0.017
|
|
|
|
regulation of protein maturation
|
GO:1903317 |
96 |
0.017
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.017
|
|
|
|
vitamin metabolic process
|
GO:0006766 |
23 |
0.017
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.017
|
|
|
|
negative regulation of cell development
|
GO:0010721 |
169 |
0.017
|
|
|
|
multi multicellular organism process
|
GO:0044706 |
109 |
0.017
|
|
|
|
potassium ion homeostasis
|
GO:0055075 |
4 |
0.017
|
|
|
|
microtubule based process
|
GO:0007017 |
236 |
0.017
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.017
|
|
|
|
cell maturation
|
GO:0048469 |
127 |
0.017
|
|
|
|
hepoxilin biosynthetic process
|
GO:0051122 |
1 |
0.017
|
|
|
|
positive regulation of satellite cell activation involved in skeletal muscle regeneration
|
GO:0014718 |
2 |
0.017
|
|
|
|
cardiac septum development
|
GO:0003279 |
59 |
0.017
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.016
|
|
|
|
regulation of actin cytoskeleton organization
|
GO:0032956 |
84 |
0.016
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.016
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.016
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.016
|
|
|
|
syncytium formation
|
GO:0006949 |
43 |
0.016
|
|
|
|
lung development
|
GO:0030324 |
164 |
0.016
|
|
|
|
g protein coupled acetylcholine receptor signaling pathway
|
GO:0007213 |
4 |
0.016
|
|
|
|
sensory perception of sound
|
GO:0007605 |
97 |
0.016
|
|
|
|
positive regulation of heart rate
|
GO:0010460 |
10 |
0.016
|
|
|
|
cell fate commitment
|
GO:0045165 |
210 |
0.016
|
|
|
|
rhythmic process
|
GO:0048511 |
174 |
0.016
|
|
|
|
positive regulation of skeletal muscle tissue regeneration
|
GO:0043415 |
4 |
0.016
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.016
|
|
|
|
sequestering of calcium ion
|
GO:0051208 |
18 |
0.015
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.015
|
|
|
|
meiotic cell cycle
|
GO:0051321 |
122 |
0.015
|
|
|
|
urea transport
|
GO:0015840 |
4 |
0.015
|
|
|
|
cell cell junction organization
|
GO:0045216 |
72 |
0.015
|
|
|
|
fat soluble vitamin biosynthetic process
|
GO:0042362 |
4 |
0.015
|
|
|
|
fc receptor mediated inhibitory signaling pathway
|
GO:0002774 |
1 |
0.015
|
|
|
|
sa node cell action potential
|
GO:0086015 |
4 |
0.015
|
|
|
|
foramen ovale closure
|
GO:0035922 |
1 |
0.015
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.015
|
|
|
|
cervix development
|
GO:0060067 |
2 |
0.015
|
|
|
|
sodium ion transport
|
GO:0006814 |
73 |
0.015
|
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.015
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.015
|
|
|
|
regulation of cell shape
|
GO:0008360 |
39 |
0.015
|
|
|
|
response to lipopolysaccharide
|
GO:0032496 |
128 |
0.015
|
|
|
|
cofactor metabolic process
|
GO:0051186 |
80 |
0.015
|
|
|
|
muscle adaptation
|
GO:0043500 |
39 |
0.015
|
|
|
|
ceramide metabolic process
|
GO:0006672 |
31 |
0.015
|
|
|
|
mitral valve morphogenesis
|
GO:0003183 |
4 |
0.015
|
|
|
|
positive regulation of lipid metabolic process
|
GO:0045834 |
40 |
0.015
|
|
|
|
regulation of blood coagulation
|
GO:0030193 |
28 |
0.015
|
|
|
|
negative regulation of t cell apoptotic process
|
GO:0070233 |
18 |
0.014
|
|
|
|
branching morphogenesis of an epithelial tube
|
GO:0048754 |
159 |
0.014
|
|
|
|
actin filament based movement
|
GO:0030048 |
23 |
0.014
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.014
|
|
|
|
myotube cell development
|
GO:0014904 |
60 |
0.014
|
|
|
|
regulation of interleukin 1 production
|
GO:0032652 |
26 |
0.014
|
|
|
|
regulation of striated muscle cell differentiation
|
GO:0051153 |
81 |
0.014
|
|
|
|
regulation of neurotransmitter levels
|
GO:0001505 |
87 |
0.014
|
|
|
|
membrane lipid metabolic process
|
GO:0006643 |
53 |
0.014
|
|
|
|
i kappab kinase nf kappab signaling
|
GO:0007249 |
85 |
0.014
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.014
|
|
|
|
potassium ion transmembrane transport
|
GO:0071805 |
43 |
0.014
|
|
|
|
angiotensin mediated vasoconstriction involved in regulation of systemic arterial blood pressure
|
GO:0001998 |
3 |
0.014
|
|
|
|
linoleic acid metabolic process
|
GO:0043651 |
6 |
0.014
|
|
|
|
positive regulation of cellular component biogenesis
|
GO:0044089 |
94 |
0.014
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.014
|
|
|
|
modification dependent protein catabolic process
|
GO:0019941 |
133 |
0.014
|
|
|
|
negative regulation of keratinocyte differentiation
|
GO:0045617 |
4 |
0.014
|
|
|
|
protein oligomerization
|
GO:0051259 |
67 |
0.014
|
|
|
|
cerebellar cortex formation
|
GO:0021697 |
22 |
0.014
|
|
|
|
dna catabolic process endonucleolytic
|
GO:0000737 |
15 |
0.014
|
|
|
|
regulation of circadian sleep wake cycle sleep
|
GO:0045187 |
3 |
0.014
|
|
|
|
negative regulation of kinase activity
|
GO:0033673 |
81 |
0.014
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.014
|
|
|
|
detection of mechanical stimulus involved in sensory perception of sound
|
GO:0050910 |
16 |
0.014
|
|
|
|
coagulation
|
GO:0050817 |
78 |
0.014
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.014
|
|
|
|
iron coordination entity transport
|
GO:1901678 |
5 |
0.014
|
|
|
|
positive regulation of translation
|
GO:0045727 |
19 |
0.014
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.014
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.014
|
|
|
|
asymmetric stem cell division
|
GO:0098722 |
3 |
0.014
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.014
|
|
|
|
monocarboxylic acid biosynthetic process
|
GO:0072330 |
61 |
0.014
|
|
|
|
positive regulation of sodium ion transmembrane transport
|
GO:1902307 |
4 |
0.014
|
|
|
|
regulation of systemic arterial blood pressure by renin angiotensin
|
GO:0003081 |
20 |
0.014
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.013
|
|
|
|
response to purine containing compound
|
GO:0014074 |
28 |
0.013
|
|
|
|
regulation of circadian sleep wake cycle
|
GO:0042749 |
3 |
0.013
|
|
|
|
endomembrane system organization
|
GO:0010256 |
147 |
0.013
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.013
|
|
|
|
acetate ester transport
|
GO:1901374 |
2 |
0.013
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.013
|
|
|
|
ventricular cardiac muscle tissue development
|
GO:0003229 |
38 |
0.013
|
|
|
|
lipid transport
|
GO:0006869 |
98 |
0.013
|
|
|
|
divalent inorganic cation transport
|
GO:0072511 |
178 |
0.013
|
|
|
|
regulation of cysteine type endopeptidase activity
|
GO:2000116 |
65 |
0.013
|
|
|
|
positive regulation of blood pressure
|
GO:0045777 |
21 |
0.013
|
|
|
|
transmission of nerve impulse
|
GO:0019226 |
76 |
0.013
|
|
|
|
mitochondrion organization
|
GO:0007005 |
134 |
0.013
|
|
|
|
odontogenesis
|
GO:0042476 |
78 |
0.013
|
|
|
|
renal water homeostasis
|
GO:0003091 |
7 |
0.013
|
|
|
|
regulation of thyroid hormone generation
|
GO:2000609 |
4 |
0.013
|
|
|
|
phenol containing compound metabolic process
|
GO:0018958 |
60 |
0.013
|
|
|
|
regulation of anagen
|
GO:0051884 |
1 |
0.013
|
|
|
|
positive regulation of growth
|
GO:0045927 |
104 |
0.013
|
|
|
|
cell matrix adhesion
|
GO:0007160 |
68 |
0.013
|
|
|
|
adenylate cyclase modulating g protein coupled receptor signaling pathway
|
GO:0007188 |
54 |
0.013
|
|
|
|
milk ejection
|
GO:0060156 |
1 |
0.013
|
|
|
|
positive regulation of steroid hormone secretion
|
GO:2000833 |
2 |
0.013
|
|
|
|
blood coagulation
|
GO:0007596 |
76 |
0.013
|
|
|
|
protein autoprocessing
|
GO:0016540 |
2 |
0.013
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.012
|
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.012
|
|
|
|
regulation of cell projection assembly
|
GO:0060491 |
38 |
0.012
|
|
|
|
positive regulation of estrogen secretion
|
GO:2000863 |
1 |
0.012
|
|
|
|
cell substrate adhesion
|
GO:0031589 |
130 |
0.012
|
|
|
|
zymogen activation
|
GO:0031638 |
41 |
0.012
|
|
|
|
embryonic nail plate morphogenesis
|
GO:0035880 |
3 |
0.012
|
|
|
|
negative regulation of mapk cascade
|
GO:0043409 |
65 |
0.012
|
|
|
|
negative regulation of b cell differentiation
|
GO:0045578 |
4 |
0.012
|
|
|
|
regulation of nucleotide catabolic process
|
GO:0030811 |
122 |
0.012
|
|
|
|
positive regulation of secretion by cell
|
GO:1903532 |
114 |
0.012
|
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.012
|
|
|
|
pigmentation
|
GO:0043473 |
71 |
0.012
|
|
|
|
cellular response to cadmium ion
|
GO:0071276 |
3 |
0.012
|
|
|
|
t cell proliferation
|
GO:0042098 |
120 |
0.012
|
|
|
|
response to phenylpropanoid
|
GO:0080184 |
22 |
0.012
|
|
|
|
spermatid development
|
GO:0007286 |
108 |
0.012
|
|
|
|
protein ubiquitination
|
GO:0016567 |
171 |
0.012
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.012
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.012
|
|
|
|
organelle fission
|
GO:0048285 |
170 |
0.012
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.012
|
|
|
|
neural retina development
|
GO:0003407 |
41 |
0.012
|
|
|
|
platelet activation
|
GO:0030168 |
40 |
0.012
|
|
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
191 |
0.012
|
|
|
|
regulation of coagulation
|
GO:0050818 |
31 |
0.012
|
|
|
|
oviduct development
|
GO:0060066 |
3 |
0.012
|
|
|
|
leukotriene production involved in inflammatory response
|
GO:0002540 |
2 |
0.012
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.012
|
|
|
|
regulation of neuronal synaptic plasticity
|
GO:0048168 |
30 |
0.012
|
|
|
|
sphingolipid metabolic process
|
GO:0006665 |
45 |
0.012
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.012
|
|
|
|
negative regulation of proteolysis
|
GO:0045861 |
74 |
0.012
|
|
|
|
cardiac chamber morphogenesis
|
GO:0003206 |
93 |
0.012
|
|
|
|
regulation of leukocyte differentiation
|
GO:1902105 |
159 |
0.012
|
|
|
|
vitamin d biosynthetic process
|
GO:0042368 |
3 |
0.012
|
|
|
|
regulation of systemic arterial blood pressure by atrial natriuretic peptide
|
GO:0003050 |
2 |
0.011
|
|
|
|
epithelial cell migration
|
GO:0010631 |
63 |
0.011
|
|
|
|
tyrosine metabolic process
|
GO:0006570 |
4 |
0.011
|
|
|
|
negative regulation of meiotic cell cycle phase transition
|
GO:1901994 |
3 |
0.011
|
|
|
|
lung induction
|
GO:0060492 |
3 |
0.011
|
|
|
|
skeletal muscle fiber development
|
GO:0048741 |
58 |
0.011
|
|
|
|
regulation of myoblast differentiation
|
GO:0045661 |
29 |
0.011
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.011
|
|
|
|
positive regulation of lipid transport
|
GO:0032370 |
22 |
0.011
|
|
|
|
interleukin 1 beta production
|
GO:0032611 |
30 |
0.011
|
|
|
|
cell junction assembly
|
GO:0034329 |
52 |
0.011
|
|
|
|
neurotransmitter transport
|
GO:0006836 |
76 |
0.011
|
|
|
|
regulation of rna polymerase ii transcriptional preinitiation complex assembly
|
GO:0045898 |
2 |
0.011
|
|
